Royal Bank Of Canada Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price target dropped by investment analysts at Royal Bank Of Canada from $110.00 to $100.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective indicates a potential upside of 22.76% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a research report on Monday, January 19th. Barclays dropped their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. BMO Capital Markets set a $85.00 target price on HealthEquity in a research note on Tuesday, February 24th. Finally, Citizens Jmp set a $122.00 target price on HealthEquity in a report on Thursday, December 4th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $111.29.

HealthEquity Trading Up 2.6%

HQY traded up $2.06 on Wednesday, hitting $81.46. The company had a trading volume of 378,499 shares, compared to its average volume of 1,019,475. The company’s fifty day moving average price is $81.30 and its 200 day moving average price is $90.27. HealthEquity has a 1 year low of $72.76 and a 1 year high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm has a market cap of $6.96 billion, a P/E ratio of 37.40, a PEG ratio of 0.98 and a beta of 0.26.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. The company had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

A number of large investors have recently made changes to their positions in the company. William Blair Investment Management LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at $169,956,000. Norges Bank purchased a new stake in HealthEquity in the fourth quarter valued at $66,927,000. Westfield Capital Management Co. LP boosted its stake in HealthEquity by 124.6% in the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Finally, Millennium Management LLC grew its holdings in shares of HealthEquity by 151.5% during the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting HealthEquity

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 beat and outlook raise — HealthEquity reported EPS $0.95 (vs. consensus ~$0.90) and revenue $334.6M, then raised its fiscal 2027 guidance — a direct catalyst supporting the stock today. HealthEquity beats Q4 estimates, raises FY27 guidance
• Positive Sentiment: Record revenue, profit and new HSAs — Company reported record full-year revenue ($1.31B, +9%) and net income of $215.2M (up 123%), and highlighted record new HSAs from sales, underpinning recurring fee growth. HealthEquity Reports Record Revenue, Earnings and New HSAs
• Positive Sentiment: Analyst upgrade citing better cash economics — Seeking Alpha upgraded the stock after management commentary and results suggested improved cash conversion and margin leverage, which can support a higher valuation multiple. HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
• Positive Sentiment: Earnings call highlighted HSA growth and strong financials — Management emphasized record HSA account growth and solid operating performance in the Q4 call, supporting confidence in recurring fees and assets under administration. HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights
• Neutral Sentiment: Full transcripts and details available — Multiple transcripts and call transcripts (Seeking Alpha, Yahoo, company release) provide longer-form detail for investors wanting to audit guidance assumptions and margin drivers. HealthEquity Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Analyst previews and metric deep dives — Pre- and post-earnings coverage (Zacks, Benzinga) compares key metrics to estimates and revises forecasts; useful for modeling but not immediate catalysts. Compared to Estimates, HealthEquity Q4 Earnings: A Look at Key Metrics

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.